Next Article in Journal
Germline TP53 Testing in Breast Cancers: Why, When and How?
Next Article in Special Issue
Whole-Body MRI for the Detection of Recurrence in Melanoma Patients at High Risk of Relapse
Previous Article in Journal
MEK1 Inhibitor Combined with Irradiation Reduces Migration of Breast Cancer Cells Including miR-221 and ZEB1 EMT Marker Expression
Previous Article in Special Issue
Disulfiram as a Therapeutic Agent for Metastatic Malignant Melanoma—Old Myth or New Logos?
 
 
Article

Article Versions Notes

Cancers 2020, 12(12), 3761; https://doi.org/10.3390/cancers12123761
Action Date Notes Link
article xml file uploaded 14 December 2020 12:48 CET Original file -
article xml uploaded. 14 December 2020 12:48 CET Update https://www.mdpi.com/2072-6694/12/12/3761/xml
article pdf uploaded. 14 December 2020 12:48 CET Version of Record https://www.mdpi.com/2072-6694/12/12/3761/pdf
article supplementary file uploaded. 14 December 2020 12:48 CET - https://www.mdpi.com/2072-6694/12/12/3761#supplementary
article html file updated 14 December 2020 12:49 CET Original file -
article html file updated 23 July 2022 05:03 CEST Update https://www.mdpi.com/2072-6694/12/12/3761/html
Back to TopTop